| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
76,182,000 |
| Market
Cap: |
12.97(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$127.77 - $330.23 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 882 |
| Guru Rank Value : 0.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Insulet is primarily engaged in the development, manufacture and sale of its proprietary Omnipod® System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes: the Omnipod Insulin Management System and the Omnipod DASH™ Insulin Management System, its digital mobile Omnipod platform. The Omnipod System features: a small, self-adhesive disposable tubeless Omnipod device (Pod) that the user fills with insulin and wears directly on the body; and the Personal Diabetes Manager, a wireless, handheld device that programs the Pod with the user's personalized insulin-delivery instructions and, wirelessly monitors the Pod's operation.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
8,851 |
8,851 |
| Total Buy Value |
$0 |
$0 |
$2,012,670 |
$2,012,670 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
3 |
3 |
| Total Shares Sold |
11,609 |
46,681 |
63,744 |
167,262 |
| Total Sell Value |
$1,891,338 |
$7,668,148 |
$12,326,709 |
$40,328,387 |
| Total People Sold |
1 |
2 |
4 |
7 |
| Total Sell Transactions |
1 |
4 |
8 |
20 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Petrovic Shacey |
President and CEO |
• • – |
2022-02-28 |
4/A |
A |
$0.00 |
$0 |
D/D |
6,347 |
33,510 |
|
- |
|
| Kapples John W. |
SVP and General Counsel |
• • – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,369 |
14,108 |
|
- |
|
| Spears Michael P |
SVP, RA and Compliance |
• • – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
661 |
16,160 |
|
- |
|
| Alpuche Charles |
EVP & Chief Operating Officer |
• • – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,361 |
49,811 |
|
- |
|
| Petrovic Shacey |
President and CEO |
• • – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,933 |
35,096 |
|
- |
|
| Budden Lauren |
Group VP, CAO and Controller |
• • – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,369 |
5,873 |
|
- |
|
| Benjamin Eric |
SVP, Innovation and Strategy |
• • – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,511 |
14,888 |
|
- |
|
| Christensen Bret |
EVP and CCO |
• • – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,361 |
22,363 |
|
- |
|
| Mcmillan Wayde D. |
EVP, CFO |
• • – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,361 |
25,943 |
|
- |
|
| Manea Dan |
SVP, Chief HR Officer |
• • – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
708 |
3,504 |
|
- |
|
| Alpuche Charles |
EVP & Chief Operating Officer |
• • – |
2022-02-26 |
4 |
D |
$262.37 |
$236,920 |
D/D |
(903) |
47,450 |
|
- |
|
| Mcmillan Wayde D. |
EVP, CFO |
• • – |
2022-02-26 |
4 |
D |
$262.37 |
$136,957 |
D/D |
(522) |
23,582 |
|
- |
|
| Christensen Bret |
EVP and CCO |
• • – |
2022-02-26 |
4 |
D |
$262.37 |
$142,205 |
D/D |
(542) |
20,002 |
|
- |
|
| Petrovic Shacey |
President and CEO |
• • – |
2022-02-26 |
4 |
D |
$262.37 |
$294,904 |
D/D |
(1,124) |
27,163 |
|
- |
|
| Spears Michael P |
SVP, RA and Compliance |
• • – |
2022-02-26 |
4 |
D |
$262.37 |
$79,236 |
D/D |
(302) |
15,499 |
|
- |
|
| Kapples John W. |
SVP and General Counsel |
• • – |
2022-02-18 |
4 |
D |
$234.18 |
$285,700 |
D/D |
(1,220) |
12,739 |
|
- |
|
| Kapples John W. |
SVP and General Counsel |
• • – |
2022-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,930 |
13,959 |
|
- |
|
| Christensen Bret |
EVP and CCO |
• • – |
2022-02-18 |
4 |
D |
$234.18 |
$652,660 |
D/D |
(2,787) |
20,544 |
|
- |
|
| Christensen Bret |
EVP and CCO |
• • – |
2022-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
7,329 |
23,331 |
|
- |
|
| Budden Lauren |
VP, CAO and Controller |
• • – |
2022-02-18 |
4 |
D |
$234.18 |
$74,235 |
D/D |
(317) |
4,504 |
|
- |
|
| Budden Lauren |
VP, CAO and Controller |
• • – |
2022-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,040 |
4,821 |
|
- |
|
| Benjamin Eric |
SVP, Innovation and Strategy |
• • – |
2022-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,308 |
13,377 |
|
- |
|
| Spears Michael P |
SVP, RA and Compliance |
• • – |
2022-02-18 |
4 |
D |
$234.18 |
$292,022 |
D/D |
(1,247) |
15,801 |
|
- |
|
| Spears Michael P |
SVP, RA and Compliance |
• • – |
2022-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
4,072 |
17,048 |
|
- |
|
| Alpuche Charles |
EVP & Chief Operating Officer |
• • – |
2022-02-18 |
4 |
D |
$234.18 |
$1,168,324 |
D/D |
(4,989) |
48,353 |
|
- |
|
683 Records found
|
|
Page 7 of 28 |
|
|
1.67 (0.97%) 
